Submitted by Anonymous (not verified) on 11 January 2024 - 8:30
Opinion/decision on a Paediatric investigation plan (PIP): Evotaz, cobicistat,atazanavir (sulfate), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0027/2023
Source: